Key indicators: single-crystal X-ray study; T = 170 K; mean (C-C) = 0.002 Å; R factor = 0.048; wR factor = 0.143; data-to-parameter ratio = 18.5.
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Cg1 is the centroid of the C1-C6 ring. Data collection: CrysAlis PRO (Oxford Diffraction, 2010); cell refinement: CrysAlis PRO; data reduction: CrysAlis RED (Oxford Diffraction, 2010); program(s) used to solve structure: SHELXS97 (Sheldrick, 2008); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008); molecular graphics: SHELXTL (Sheldrick, 2008); software used to prepare material for publication: SHELXTL. 5-(Biphenyl-4-yl)-3-(3-methoxybenzylidene)furan-2(3H)-one J. P. Jasinski, J. A. Golen, A. S. Dayananda, H. S. Yathirajan and R. Mishra
Comment
Certain drugs containing a furanone structure were potential anti-ulcer agents because they did not irritate the lining of the stomach (Felman et al., 1992) . Their occurrence in nature has been exploited in the pharmaceutical industry because of their unusual biological activities, such as anti-ulcer and anti-cancer treatments. The antitumor activity of several analogs of furanones was evaluated using both in vivo and in vitro methods on mice, where oral adminstration showed a relative decrease in tumor growth. In an effort to create more efficient drugs, scientists began to explore the role of furanones in the biochemical processes of the human body (Rappai et al., 2009) . The gastrointestinal toxicity of acidic non-steroidal anti-inflammatory drugs (NSAIDs) is one of the most challenging problems in medicinal chemistry (Husain et al., 2010) .
NSAIDs form a class of therapeutic agents that are most widely used world over because of their antiinflammatory, analgesic and antipyretic effects. Aroylpropionic acids and furanones are effective anti-inflammatory agents and some of them are available in the market, however, they are associated with gastrointestinal side effects; a common feature of NSAIDs (Cioli et al., 1979) . Studies suggest that the direct tissue contact of these agents plays an important role in the production of side effects and the reported literature confirms that gastrointestinal side effects of aroylpropionic acids are due to the presence of the free carboxylic group in the parent drug. This free carboxylic group, therefore, has been converted to the furanone ring to get a compound free from GIT side effects. Furanones and b\-aroylpropionic acids are important intermediates in heterocyclic chemistry and have been used for the synthesis of various biologically active five-membered heterocyles such as butenolides, pyrrolones (Husain et al., 2005; Khan et al., 2002) oxadiazoles (Husain et al., 2009 ) and triazoles (Hashem et al., 2007) . The crystal structure study of a related compound, (E)-6-methoxy-3-( -methoxybenzylidene)benzo[b]furan-2(3H)-one, at 173 K is reported (Burke et al., 2000) . In view of the importance of the title compound, (I), this paper reports its crystal structure.
In the title molecule, the dihedral angles between the mean planes of the five-menbered furan ring and the methoxy substituted benzene and biphenyl benzene rings are 2.43 (7)°, 4.48 (7)°, and 30.47 (8)°, respectively ( Fig. 1 ). Bond lengths are in normal ranges (Allen et al., 1987) . The crystal packing is stabiized by weak C-H···O and C-H···π intermolecular hydrogen bonds and π-π stacking (Table 2) interactions ( Fig. 2) .
Experimental
A solution of 3-(4-phenylbenzoyl)propionic acid (0.71 g, 3 mmol) and 3-methoxybenzaldehyde (0.45 g, 3 mmol) in a acetic anhydride (5 ml) with triethylamine (3-4 drops) was refluxed for 5-6 hrs on a water bath under anhydrous conditions. After completion of the reaction, the contents were poured into crushed ice in small portions while stirring. A solid mass separated out, which was filtered, washed with water and crystallized from 2-butanone to get X-ray quality crystals (m.p. 411-413 K).
supplementary materials sup-2 Refinement All of the H atoms were placed in their calculated positions and then refined using the riding model with C-H lengths of 0.95 Å (CH) or 0.98 Å (CH 3 ). The isotropic displacement parameters for these atoms were set to 1.18-1.21 (CH) or 1.49 (CH 3 ) times U eq of the parent atom. Refinement. Refinement of F 2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F 2 , conventional R-factors R are based on F, with F set to zero for negative F 2 . The threshold expression of F 2 > σ(F 2 ) is used only for calculating Rfactors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F 2 are statistically about twice as large as those based on F, and R-factors based on ALL data will be even larger.
Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å 2 )
x y z U iso */U eq O1 0.71593 (5) 0.0317 (7) 0.0508 (9) 0.0608 (10) −0.0004 (6) 0.0174 (7) −0.0006 (8) C3
0.0302 (7) 0.0584 (10) 0.0535 (10) 0.0033 (7) 0.0026 (7) −0.0021 (8) C4
0.0437 (8) 0.0595 (11) 0.0415 (8) 0.0041 (7) 0.0048 (7) 0.0051 (7) C5 0.0378 (7) 0.0458 (9) 0.0401 (8) −0.0024 (6) 0.0121 (6) 0.0039 (6) C6 0.0296 (6) 0.0338 (7) 0.0364 (7) 0.0029 (5) 0.0110 (5) −0.0006 (5) supplementary materials sup-5 C7 0.0293 (6) 0.0323 (7) 0.0342 (7) 0.0012 (5) 0.0110 (5) 0.0009 (5) C8 0.0340 (7) 0.0550 (9) 0.0312 (7) −0.0010 (6) 0.0125 (6) −0.0033 (6) C9 0.0300 (7) 0.0542 (9) 0.0360 (7) −0.0004 (6) 0.0150 (6) −0.0035 (6) C10 0.0298 (6) 0.0325 (7) 0.0334 (7) 0.0005 (5) 0.0114 (5) 0.0007 (5) C11 0.0362 (7) 0.0453 (8) 0.0301 (7) 0.0011 (6) 0.0133 (5) −0.0012 (6) C12 0.0305 (6) 0.0445 (8) 0.0379 (7) 0.0015 (6) 0.0166 (6) −0.0010 (6) C13 0.0343 (7) 0.0370 (7) 0.0281 (6) 0.0008 (5) 0.0106 (5) −0.0007 (5) C14 0.0305 (6) 0.0393 (7) 0.0302 (7) 0.0004 (5) 0.0102 (5) −0.0002 (5) C15 0.0334 (7) 0.0345 (7) 0.0298 (6) 0.0028 (5) 0.0115 (5) 0.0018 (5) C16 0.0333 (7) 0.0504 (9) 0.0307 (7) 0.0027 (6) 0.0108 (6) 0.0024 (6) C17 0.0328 (7) 0.0409 (8) 0.0279 (6) 0.0027 (6) 0.0088 (5) 0.0030 (5) C18 0.0311 (6) 0.0332 (7) 0.0310 (6) 0.0011 (5) 0.0091 (5) 0.0005 (5) C19 0.0327 (7) 0.0397 (8) 0.0289 (6) 0.0001 (5) 0.0085 (5) −0.0001 (5) C20 0.0294 (6) 0.0403 (8) 0.0379 (7) −0.0007 (5) 0.0086 (6) −0.0009 (6) C21 0.0375 (7) 0.0530 (9) 0.0401 (8) 0.0002 (6) 0.0196 (6) −0.0016 (7) C22 0.0454 (8) 0.0560 (10) 0.0309 (7) 0.0006 (7) 0.0140 (6) −0.0016 (6) C23 0.0323 (7) 0.0486 (8) 0.0320 (7) 0.0003 (6) 0.0067 (5) 0.0003 (6) 
Hydrogen-bond geometry (Å, °)
Cg1 is the centroid of the C1-C6 ring. (6) Cg2 and Cg3 are the centroids of rings O1/C13-C16 and C18-C23, respectively. Symmetry codes: (i) 1-x, -1/2+y, 1/2-z; (ii) 1-x, 1/2+y, 1/2-z.
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